Greenwich LifeSciences Inc. (GLSI) Social Stream
GREENWICH LIFESCIENCES INC (GLSI) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering GREENWICH LIFESCIENCES INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-29 | 1 | $78 | $78 | $78 | $10.42 | 648.56% |
| 2023-04-10 | 1 | $38 | $38 | $38 | $10.42 | 264.68% |
Price Target Last Issued November 29, 2022
The Trend in the Analyst Price Target
Over the past 20 months, GLSI's average price target has gone down $37.
500 - Internal server error
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-10 | 1 | 38 | 38 | 38 | 12.65 | 200.4% |
GLSI Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
Over the past 17 months, GLSI's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- GREENWICH LIFESCIENCES INC's number of analysts covering the stock is higher than nearly none of all US stocks.
- GLSI has a lower variance in analysts' estimates than almost 100% of all US stocks.
- In the context of stocks in the small market cap category, GREENWICH LIFESCIENCES INC's average analyst price target is greater than 180.23% of them.
- GLSI has a greater upside potential (average analyst target price relative to current price) than 159.7% of stocks in the small market cap category.
Stocks similar to GREENWICH LIFESCIENCES INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are GLTO, OLMA, and KNTE.
View All Top Stocks by Price Target
Is GLSI a Buy, Hold or Sell? See the POWR Ratings now!